Lixisenatide (LYXUMIA): the third GLP-1 receptor agonist in type 2 diabetes

New indication: tadalafil (CIALIS) against lower urinary tract symptoms secondary to benign prostatic hyperplasia

Fumaric acid esters (FUMADERM) in psoriasis

Buccal midazolam (BUCCOLAM) against seizures in children and adolescents

New Data on pneumococcal vaccine in children

Antihistamine doxylamine approved for pregnant women experiencing nausea and vomiting

Guideline against misleading and trivialising tradenames

Ophthalmic agents with phosphate buffers: corneal calcification

New restrictions in the use of strontium ranelate (PROTELOS

Cardiac harms and bleeding with cilostazol (PLETAL)

GLP-1 based therapies damage the pancreas

EMA recommends suspension of the marketing authorization of tetrazepam (MUSARIL, generics)

Vitamin C: risk of kidney stones increased

© arznei-telegramm 4/2013